Proceedings of the 12th Annual Scientific Meeting, Medical Faculty, Universitas Jenderal Achmad Yani, International Symposium on "Emergency Preparedness and Disaster Response during COVID 19 Pandemic" (ASMC 2021)

<Previous Article In Volume
Next Article In Volume>

Elevated Cardiac Marker Enzymes with the Incidence of Complications in ACS Patients:

Is it Related?

Authors
Prihati Pujowaskito, Muhammad Aldiast Alhadiyanto, Wida Vianita Aziz, Muhammad Hanif Baswedan
Corresponding Author
Prihati Pujowaskito
Available Online 24 July 2021.
DOI
10.2991/ahsr.k.210723.058How to use a DOI?
Keywords
ACS, cardiac marker enzymes, CKMB, complications, troponin
Abstract

Acute coronary syndrome (ACS) is a condition that describes the condition of the heart muscle infarction so that the heart is damaged. Ongoing damage to the heart muscle may result in a new condition known as a complication. Based on this condition, the aim of this study was to determine the relationship between elevated cardiac marker enzymes and the incidence of complications in ACS patients. This study is an observational analytic study based on secondary data, namely medical record data. The subjects of this study were data from medical records of SKA patients who experienced complications recorded in the medical records at the Dustira Cimahi Hospital in 2018. The number of cases found in the Dustira hospital in 2018 was 105 cases, the most age was over 45 years, the sex that often experienced complications was women with a total of 58 people (55.2%), cardiac enzymes both troponin and CKMB in cases experienced a significant increase, patients with troponin increase was 86 people (81.9%) while patients with increased CKMB were 88 people (92.6%), complications were obtained by patients with heart failure as many as 38 cases, cardiogenic shock as many as 16 people, arrhythmia as many as 30 people, as many as 11 people, and cardiac arrest as many as 10 people. In this study, it was concluded that there was a significant relationship between the increase in cardiac marker enzymes both troponin and CKMB (p-value <0.05) on the incidence of complications in ACS patients.

Copyright
© 2021, the Authors. Published by Atlantis Press.
Open Access
This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)

<Previous Article In Volume
Next Article In Volume>
Volume Title
Proceedings of the 12th Annual Scientific Meeting, Medical Faculty, Universitas Jenderal Achmad Yani, International Symposium on "Emergency Preparedness and Disaster Response during COVID 19 Pandemic" (ASMC 2021)
Series
Advances in Health Sciences Research
Publication Date
24 July 2021
ISBN
978-94-6239-408-7
ISSN
2468-5739
DOI
10.2991/ahsr.k.210723.058How to use a DOI?
Copyright
© 2021, the Authors. Published by Atlantis Press.
Open Access
This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Cite this article

risenwbib
TY  - CONF
AU  - Prihati Pujowaskito
AU  - Muhammad Aldiast Alhadiyanto
AU  - Wida Vianita Aziz
AU  - Muhammad Hanif Baswedan
PY  - 2021
DA  - 2021/07/24
TI  - Elevated Cardiac Marker Enzymes with the Incidence of Complications in ACS Patients:
BT  - Proceedings of the 12th Annual Scientific Meeting, Medical Faculty, Universitas Jenderal Achmad Yani, International Symposium on "Emergency Preparedness and Disaster Response during COVID 19 Pandemic" (ASMC 2021)
PB  - Atlantis Press
SP  - 249
EP  - 253
SN  - 2468-5739
UR  - https://doi.org/10.2991/ahsr.k.210723.058
DO  - 10.2991/ahsr.k.210723.058
ID  - Pujowaskito2021
ER  -